Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Aveanna Healthcare Holdings Inc. (AVAH) had Cost of Goods Sold of $1.62B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$2.43B
Net Income	$225.03M
Cost of Goods Sold	$1.62B
Gross Profit	$810.48M
Operating Expenses	$2.18B
Operating Income	$256.46M
Non-Operating Income/Expense	$-149.51M
Pre-Tax Income	$106.95M
Normalized Pre-Tax Income	$106.95M
Income after Taxes	$225.03M
Income from Continuous Operations	$225.03M
Consolidated Net Income/Loss	$225.03M
Normalized Income after Taxes	$225.03M
EBIT	$256.46M
EBITDA	$290.54M
Weighted-Average Shares Outstanding (Basic)	203.53M
Weighted-Average Shares Outstanding (Diluted)	214.98M
Earnings per Share (EPS) (Basic)	$1.11
Earnings per Share (EPS) (Diluted)	$1.05
Balance Sheet Financials
Current Assets	$560.23M
Property, Plant, and Equipment	$16.65M
Long-Term Assets	$1.45B
Total Assets	$2.01B
Current Liabilities	$424.46M
Long-Term Debt	$1.29B
Long-Term Liabilities	$1.39B
Total Liabilities	$1.82B
Common Equity	$194.46M
Tangible Shareholders Equity	$-1.02B
Shareholders Equity	$194.46M
Common Shares Outstanding	211.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$125.86M
Cash Flow from Investing Activities	$-22.30M
Cash Flow from Financial Activities	$5.41M
Beginning Cash	$84.29M
End Cash	$193.26M
Increase/Decrease in Cash	$108.97M
Stock-Based Compensation	$25.06M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.32
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.87
Debt to Equity Ratio	7.53
Gross Margin	33.31%
Operating Margin	10.54%
EBIT Margin	10.54%
EBITDA Margin	11.94%
Pre-Tax Profit Margin	4.40%
Profit Margin	9.25%
Free Cash Flow	$118.41M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.21
Inventory Turnover	--
Receiveable Turnover	7.70
Days Sales in Receivables	47.42
Return on Equity	115.72%
Return on Tangible Equity	-22.08%
Return on Assets	11.18%
Return on Investments	15.19%
Book Value Per Share	$0.92
Free Cash Flow per Share	$0.55
Operating Cash Flow per Share	$0.59

Data from Zacks Investment Research, Inc.